Gregory Ferenstein
Gregory Ferenstein is a senior fellow in drug policy at Reason Foundation.
-
FAQ: Timeline for FDA ibogaine approval
It can take between 5 and 12 years to complete a drug trial, but the timeline to drug approval can vary significantly depending on the type of treatment.
-
Psychedelic drug policy recommendations for the incoming Trump administration
The incoming Trump administration has promised sweeping reforms, and that might include reversing the federal suppression of psychedelics.
-
A policy framework for personal psychedelics licenses
Psychedelic licenses for consumers have advantages over the current approach in two U.S. states that rely on professionals to dispense and facilitate services.